June 18, 2014
EATONTOWN, N.J. — (Press Release) — June 18 2014 — American CryoStem Corporation (OTCQB: CRYO), a leading strategic developer, marketer and global licensor of patented adipose […]
April 24, 2014
EATONTOWN, N.J. — (GlobeNewsWire) — April 24, 2014 — American CryoStem Corporation (OTCQB:CRYO), a leading biotechnology developer and licensor of patented adipose tissue-based adult stem cell […]
April 9, 2014
AMERICAN CRYOSTEM AND RUTGERS UNIVERSITY FILE JOINT PATENT ON ADIPOSE-DERIVED STEM CELL PLATFORM TECHNOLOGY Combined Technologies Create Basis for Joint Development of Multi-Functional Nanotechnology Platforms EATONTOWN, […]
April 9, 2014
EATONTOWN, N.J. — (GlobeNewsWire) — April 9, 2014 — American CryoStem Corporation (OTCQB: CRYO), a leading biotechnology developer and global licensor of patented adipose tissue-based adult […]
April 8, 2014
EATONTOWN, N.J. — (MEDIA ADVISORY) — April 8, 2014 — American CryoStem Corporation (OTCQB: CRYO), a leading strategic developer, marketer, and global licensor of patented adipose […]
January 13, 2014
EATONTOWN, N.J. – January 13, 2014 – American CryoStem Corporation (OTCQB: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies […]
January 6, 2014
Dear Fellow Shareholders: Business Partners and Friends: Advancements in Regenerative Medicine have been notably pronounced over the past year, helping to fuel the growing global excitement […]
November 14, 2013
EATONTOWN, N.J. – (GlobeNewsWire) – November 14, 2013 – American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular […]
July 22, 2013
American CryoStem Corporation (OTCQB: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, […]